Tag: ovarian cancer
NHS Approves First New Ovarian Cancer Drug in 20 Years for Resistant Disease
NHS approves mirvetuximab soravtansine, the first new ovarian cancer treatment in over 20 years for women with platinum-resistant disease. The…
Genomic instability fuels cancer resistance through newly identified cellular pathway
New research reveals how genomic instability in ovarian cancer activates the STING-WNT pathway, creating protective myofibroblasts that drive both immune…
Submit Your Paper to GMJ
No APC until January 2027.